Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Shares Outstanding (Diluted Average) (2023 - 2026)

BioScience Health Innovations has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $11.4 million for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) fell 74.34% to $11.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.4 million through Mar 2026, down 74.34% year-over-year, with the annual reading at $11.4 million for FY2025, 4.54% up from the prior year.
  • Shares Outstanding (Diluted Average) was $11.4 million for Q1 2026 at BioScience Health Innovations, roughly flat from $11.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $44.3 million in Q1 2025 and troughed at $10.9 million in Q3 2024.
  • The 4-year median for Shares Outstanding (Diluted Average) is $31.4 million (2023), against an average of $26.6 million.
  • Year-over-year, Shares Outstanding (Diluted Average) increased 7.11% in 2025 and then tumbled 74.34% in 2026.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $33.8 million in 2023, then crashed by 67.71% to $10.9 million in 2024, then increased by 4.54% to $11.4 million in 2025, then dropped by 0.2% to $11.4 million in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Shares Outstanding (Diluted Average) are $11.4 million (Q1 2026), $11.4 million (Q4 2025), and $11.4 million (Q3 2025).